Elevance Health will no longer be able to enroll individuals into its Medicare Advantage plans starting March 31, following a suspension notice from the Centers for Medicare and Medicaid Services (CMS) that cites years of regulatory noncompliance.
This suspension is a direct consequence of Elevance’s failure to provide required information to federal regulators over a span of seven years. While the suspension will not impact the 1.9 million current enrollees, it raises significant concerns about Elevance’s operational integrity and compliance practices. The implications of this action could be severe, as CMS rarely imposes such sanctions, which could financially destabilize Elevance if corrective measures are not implemented before the Medicare annual enrollment period in October.
CMS has indicated that enrollment could remain open if Elevance takes prompt action to address the cited issues this month. However, the immediate market reaction has been negative, with Elevance’s shares dropping more than 8% on Monday, reflecting investor apprehension regarding the company’s future performance.
Open the full market picture for your next decision →
